Fitness to Practise Cases

This archive contains General Pharmaceutical Council (GPhC) Fitness to Practise (FtP) case summaries, detailing regulatory decisions affecting pharmacy professionals in the UK.

Each case provides insight into professional misconduct, errors, and ethical breaches that led to sanctions such as suspension, removal, or warnings. These summaries are valuable for:

  • Pharmacists & Pharmacy Technicians – to understand common regulatory pitfalls.
  • Employers & HR Teams – to learn about professional accountability and compliance.
  • Pharmacy Students – to prepare for real-world ethical challenges in pharmacy practice.

Why it matters:

The decisions in these cases shape the legal and ethical landscape of pharmacy practice. Staying informed can help pharmacy professionals avoid similar mistakes and maintain high professional standards.

Use the form below to search for and filter cases that match your interests


Found 472 Results
Page 14 of 48

Pharmacist Suspended for Inadequate Prescribing Practices of Saxenda via Online Consultations


Allegations The registrant, a pharmacist and Superintendent Pharmacist at Burwash Pharmacy, faced a series of serious allegations relating to the unsafe prescribing of Saxenda, a prescription-only weight loss medication. Between 2019 and 2022, Saxenda was issued through online consultations with patients, primarily relying on self-reported questionnaires without robust clinical verification. Concerns were raised by healthcare […]

22 October 2025


Pharmacist Warned for Remotely Approving Prescriptions via WhatsApp While Pharmacy Operated Unsupervised


Allegations This case revolves around a registered pharmacist who served as the Responsible Pharmacist at Swindon Pharmacy on six specified dates in late 2022 and mid-2023. Despite being officially responsible, the registrant was not physically present at the pharmacy on any of those dates. Critically, while the pharmacy was operational without a pharmacist on-site, prescription […]

20 October 2025


Superintendent Pharmacist Warned Over Lapses in Online Pharmacy Governance and Controlled Drug Wholesale Export


Allegations This case revolves around serious allegations concerning the registrant’s conduct during her tenure as Superintendent Pharmacist (SI) at Dock Pharmacy in Tilbury, Essex, from February to June 2021. The core concern relates to the registrant’s failure to appropriately oversee and manage the risks associated with the pharmacy’s online operations. During this period, the pharmacy […]

19 October 2025


Suspended Sentence for NI Superintendent Pharmacist Following Prolonged Unlawful Supply of Controlled Drugs


Allegations This case involves serious and sustained misconduct by the registrant, a superintendent pharmacist and director of Castlereagh Pharmacy Ltd, who was convicted of multiple criminal offences and found to have repeatedly breached professional standards and legal obligations. Between 2017 and 2020, the registrant unlawfully supplied significant quantities of prescription-only and controlled drugs, including Co-codamol, […]

14 October 2025


Warning Issued for Inadequate Oversight of High-Risk Online Ozempic Prescribing Service by Superintendent Pharmacist


Allegations This case concerns a superintendent pharmacist who was issued a warning by the GPhC’s Investigating Committee for serious governance failures surrounding the operation of an online prescribing service. The registrant, who is the Director and Superintendent of My London Pharmacy, initiated the service through the domain mylondonpharmacy.com around June 2022. The key allegation centred […]


Pharmacist Issued Warning Over Improper Mezolar Claims for Discontinued Medication


Allegations The case revolved around the registrant, a superintendent pharmacist, who submitted false claims for Mezolar—a Schedule 2 controlled drug—between April 2017 and December 2018. The medication had been discontinued for the patient, his mother, in April 2017 following a switch to Butec patches. Despite this, prescriptions containing Mezolar continued to be received and submitted […]


Pharmacist Suspended After Failing to Comply with Conditions Over Controlled Drugs and Dispensing Errors


Allegations The registrant, a pharmacist, faced a review hearing following serious professional failings identified during a previous principal hearing held in 2018. The original allegations related to a range of misconduct spanning approximately six months, from August 2016 to February 2017. These included multiple dispensing errors, breaches of Controlled Drugs (CDs) legislation, and poor record-keeping. […]

10 October 2025


Pharmacist Suspended After Conviction for Falsely Accusing Stranger to Dodge Speeding Fines


Allegations This case concerns a conviction unrelated to direct pharmacy practice but which significantly questioned the registrant’s personal integrity—an essential attribute for pharmacists. On 30 December 2022, the registrant was convicted at Bradford Crown Court for conspiracy to pervert the course of justice. The conviction stemmed from two speeding offences on 11 April 2020, when […]

7 October 2025


Pharmacy Technician Consumed 56 Codeine Tablets Daily at Work – GPhC Lifts Suspension After Evidence of Rehabilitation


Allegations In a deeply concerning case for the pharmacy profession, a pharmacy technician was found to have dishonestly removed and consumed large quantities of medications—namely codeine, a controlled drug, and Orlistat, a prescription-only medicine—while at work. The misconduct occurred over several weeks between June and October 2016. The registrant had no valid prescriptions for either […]

4 October 2025


Pharmacist Cleared to Return to Practice After Public Indecency Caution and Regulatory Breach


Allegations The pharmacist in this case was the subject of a Fitness to Practise investigation after accepting a conditional police caution for a serious act of public indecency. The caution arose from an incident in which the registrant was observed by a member of the public, Witness A, in a supermarket car park, with his […]

2 October 2025


Page 14 of 48